Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
Sponsor: Jade Biosciences, Inc.
Summary
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
Official title: A Phase 1, Open-label, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Japanese and Chinese Participants.
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-05
Completion Date
2027-05
Last Updated
2026-04-15
Healthy Volunteers
Yes
Conditions
Interventions
JADE101
JADE101 is supplied as sterile solution to be administered by SC injection
Locations (1)
Parexel Early Phase Clinical Unit (EPCU)
Glendale, California, United States